Contract Development Manufacturing Organizations Market Procurement Intelligence, Pricing and Supplier Ranking Report

 The growth of Contract Development Manufacturing Organizations and the manufacturing of APIs has been credited to a rise in the demand for generic drugs, patent expirations, and biological innovations. However, the COVID-19 pandemic has drastically increased the demand for innovations and generic drugs, recently. Although there has been an increased demand for APIs catering to these fields, the supply of API has proved challenging.

The pandemic has resulted in business lockdowns in several parts of the world. China is the first country to face the devastations of the pandemic and as such has extended periods of lockdown. This resulted in over 44 Chinese API manufacturers closing their operations temporarily due to the government-imposed lockdown restrictions. Since China is a leading API manufacturing hub and also the major region, where the raw materials for API manufacturing are found, these non-operational Chinese CDMOs severely affected the supply of API at a global scale.

Various countries and governments worldwide have opted to boycott APIs made in China. However, this also means that they need to either manufacture or source API from other regions. This dichotomy in the decision versus the supply scenario has resulted in two major changes. First, other regions like Singapore, Belgium, and India are focusing more on API manufacturing, thereby aiming to become the API hubs of the future. Also, corporates are focusing on CDMO from multiple regions to serve locally, thereby omitting the chances of supply chain disruptions like the ones caused by the COVID-19 pandemic. They are also looking to operate from countries where CDMO can import from Chinese players.

CDMO API Manufacturing Category Intelligence Highlights:

• The CDMO API manufacturing market features a fragmented competitive landscape and several small players are entering the market. However, several mergers and acquisitions are happening recently. The market is expected to consolidate in future
  
  
• Suppliers widely prefer approved provider operating models to reduce risks and improve the potential for value creation
  
  
• Value-based pricing models have become one of the most commonly used pricing strategies recently

Read report summary or request a free sample copy of the report “Contract Development Manufacturing Organization Market Procurement Intelligence, Supplier Intelligence & Ranking, Pricing & Cost Structure Intelligence, Best Practices, Engagement Model, Low & Best Cost Country, Day One Analysis Report, 2020 – 2025”

CDMO Cost Intelligence Highlights:

Grand View Research has identified the following key cost components for availing CDMO API manufacturing:

• Project Planning and Management Costs
  
  
• Drug Product Analytical Development
  
  
• Batch Manufacturing CostsSupplier Management

•       Filter Validation
•       Creation of Batch Records
•       Raw Material Costs
•       Machinery and Accessory Cost
•       Vile Production Costs
•       Other GMP Batch Production Costs
•       Stability Studies

• Operational Costs

• Insurance
• Freight
• Service Fee
• Storage
• Admin

Batch manufacturing cost is the major cost component of a CDMO API manufacturer, accounting for 65% of the total cost of manufacturing.

Operational Capabilities - Weightage

• Years in Service15%
• Geographical Service Presence30%
• Employee Strength5%
• Revenue Generated10%
• Key Clients10%
• Certifications30%

Functional Capabilities - Weightage

Use molecule 35%

• Cyclosporine
• Tetracycline
• Daptomycin
• Vancomycin
• Steroids
• Others

Type 30%

• Innovative
• Generic

Sysnthesis 20%

• Biotech type
• Synthetic type

Other functionalities offered by CMOs 15%

List of Key Suppliers in the CDMO API manufacturing market

• Pantheon
• Evonik
• Lonza
• AMRI
• Siegfried
• Fabbrica Italinana Sintetici
• Hovione
• Esteve

Find More Reports by Grand View Research

• Electric Vehicle Charging Connector Market - https://www.grandviewresearch.com/pipeline/release/global-electric-vehicle-charging-connector-market-procurement-intelligence  

• Blister Packaging Market - https://www.grandviewresearch.com/pipeline/blister-packaging-market-procurement-intelligence-report  

• Electric Vehicle Charging Connector Market - https://www.grandviewresearch.com/pipeline/electric-vehicle-charging-connector-market-procurement-intelligence-report 

ECG Equipment Market Research Methodology, Scope & Assumption

 The global ECG Equipment Market size is expected to value at USD 6.3 billion by 2022. The ECG equipment industry is subject to witness a substantial growth due to increasing occurrence of chronic diseases, changing food patterns, significant adoption of ECG monitoring systems by healthcare professionals, and ease of operation of these devices. Increasing demand from healthcare specialists coupled with growing health-conscious population is expected to drive the growth of ECG equipment market over the forecast period.

Furthermore, rise in the number of awareness initiatives by local governments are anticipated to offer growth opportunities for market players in the near future. However, strict laws and guidelines adopted by regional governments and lack of availability of skilled professionals are restricting the market growth, in the recent years.

Changing lifestyle and varying eating habits have steered rising occurrence cardio-vascular diseases among young as well as elderly population. High-calorie diet and lesser physical exercise are contributing to rising number of incidences of cardio-vascular diseases such as arteriosclerosis and high blood pressure. The common factors such as ever-growing pollution with the rapid industrialization and urbanization, are contributing to the respirational disorder, attributing to the demand for ECG equipment.

An ECG equipment offers smart diagnosis based treatment with the help of highly accurate diagnosis of physiological parameters in the real-time. An ECG system is able to predict and facilitate diagnostic needs of patients. The ECG systems provide highly accurate test results that helps in further treatment of patients suffering from cardo-vascular disorders. Globally, the ECG equipment industry is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market players to invest for research and development in the ECG equipment market.

ECG monitoring alongside multiple sensor data fusion techniques are typical methodologies implemented to enhance system capabilities by utilizing integral redundancy in data with the help of a sensor and signal processing. ECG machines are vital for diagnosis in extreme conditions and critical situations in which the diagnosis of inherently interlinked signals is needed. The application of the electrocardiogram (ECG) equipment includes intensive care units, battlefield medical facility and outer-space operations. These systems prevent possibilities of data misinterpretation, responsible for raising false alarms only to offer a high degree of precision in its results with the help of data aggregation and fusion.

The ECG equipment industry is broadly categorized into five major segments based on the product type such as holter monitors, resting ECG system, stress ECG monitors, event monitoring systems and ECG management systems. The ECG management system is considered as one of the fastest growing segment in the market with a substantial revenue generation in the last few years. Growing popularity of the ECG management system segment is attributed to the increasing adoption by numerous healthcare facilities and their cost-effectiveness. The holter monitors segment has also witnessed a substantial growth due to the highly accurate results and lower cost.

Request a Free Sample Copy of ECG Equipment Market Report @  https://www.millioninsights.com/industry-reports/ecg-equipment-market/request-sample

The ECG equipment market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in implementation of latest technologies in healthcare sector, increasing number of research & development activities by prominent industry participants and existence of well-established medical facilities. Asia-Pacific region is predicted to hold a major market share in the ECG equipment with massive growth in forecast period.

Countries such as India, China and Singapore are leading the Asia-Pacific market with increasing number of medical facilities in the region, growing healthcare expenditure by local governments, increasing disposable income and significant investment by leading industry players considering potential growth opportunities in the region.

The key players in the ECG equipment industry are BioTelemetry, Inc., Compumed Inc., GE Healthcare, Inc., Mindray Medical Co., Hill Rom Ltd., NIHON KOHDEN Co., Philips Healthcare, Inc., Schiller Group AG, Spacelabs Healthcare, Inc., Welch Allyn, Inc., CardioComm Solutions, Inc., McKesson Co., Device Technologies, Inc., and Medical Information Technology, Inc.

Market Segment:

ECG equipment regional outlook (Revenue, USD Million, 2012 - 2022)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Asia Pacific
• Japan
• China
• India
• RoW
• Australia
• Brazil

The report “ECG Equipment Market Size & Forecast Report, 2012 - 2022” is available now at   https://www.millioninsights.com/industry-reports/ecg-equipment-market

ECG equipment type outlook (Revenue, USD Million, 2012 - 2022)
• ECG Monitoring Equipment
• Holter Monitoring Systems
• Event Monitoring Systems
• ECG Stress Testing Systems

Medical Marijuana Market Is Expected To Value At USD 55.8 Billion By 2025

 The global Medical Marijuana Market size is expected to value at USD 55.8 billion by 2025. The market is subject to witness a substantial growth due to the rise in number of medical applications such as pain management, appetite enhancement, and reducing eye pressure. Medical marijuana is broadly classified into two types based on their orientation such as Cannabis Sativa and Cannabis indica. The Cannabis Sativa and Cannabis indica are naturally found in the western hemisphere and central & south Asian region respectively. Globally, the medical marijuana industry is predicted to grow at CAGR of 17.1% in forecast period, providing numerous opportunities for market players to invest for research and development in the market.

Rise in the approval rate of medical marijuana in different parts of the globe is expected to boost market demand for cannabis in therapeutic applications. Additionally, growing competition in the market coupled with rising number of mergers and acquisitions in the medical marijuana market is anticipated to stimulate market development over the coming few years. The technological advancements in the healthcare industry coupled with development of innovative drugs are some of the key factors for sustained market growth.

Increasing number of states with lawful legalizing medical marijuana in U.S. and high-end demand for cannabis in medical and recreational applications are predicted to favor market growth over the forecast period. Rise in the number of research and development activities in North America and Europe is also expected to fuel the demand for the drug in the near future.

Growing awareness of medical marijuana among general population coupled with increasing preference amongst the academic researchers and healthcare professionals associated with the therapeutic uses of marijuana are considered as the significant factors, which are propelling the market expansion over the coming years. Some of the potential therapeutic application of the medical marijuana are vomiting & nausea, pain relief, and appetite stimulation. Increasing adoption of medical marijuana providing pain relief for the patient suffering from HIV/AIDS, glaucoma, cancer, and multiple sclerosis diseases is projected to escalate market growth in the upcoming years. Therapeutic is one of the key application of the drug, thus propelling the market over the forecast period.

The medical marijuana industry is broadly categorized into four major segments based on the application type such aschronic pain management segment, arthritis pain management segment, migraine pain management segment, cancer cell segment. The chronic pain management is considered as one of the fastest growing segment in the medical marijuana market with substantial revenue generation in the last few years. Growing popularity of the medical marijuana in chronic pain management segment is attributed to the rising usage of cannabis in pain management. The cancer cell segment has also witnessed substantial growth owing to the rise in number of studies showcasing cancer cell destroying capabilities of medical marijuana.

Request a Free Sample Copy of Medical Marijuana Market Report @  https://www.millioninsights.com/industry-reports/medical-marijuana-market/request-sample

The medical marijuana industry is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the implementation of latest technologies in medicine & pharmaceutical sector, surging pace of cannabis legalization in the U.S. and Canada, and existence of well-established healthcare infrastructure in the region.

European regions are predicted to hold major market share in the medical marijuana market displaying a massive growth in forecast period. Countries such as Belgium, Croatia, Italy, Netherland, Finland, France and Portugal are leading the European market due to rising approval rate, increasing consumer awareness associated with health benefits of medical marijuana, growing market penetration with specialized departmental stores for medical marijuana, and significant investment by leading industry players considering potential growth opportunities in the region.

The key players in the medical marijuana industry are Cara Therapeutics Inc., Cannabis Sativa, Inc., CannaGrow Holdings, Inc., United Cannabis Co., Growblox Sciences, Inc., GreenGro Technologies, Inc., GW Pharmaceuticals plc, International Consolidated Companies, Inc., and Lexaria Co.

Market Segment:

Regional Outlook (Market Revenue in USD Million, 2013 - 2025)
• North America
• U.S.
• Canada
• Europe
• Belgium
• Croatia
• Finland
• France
• Italy
• Netherlands
• Portugal
• Romania
• Switzerland
• Czech Republic
• Estonia
• ROW
• Israel

For further inquiries, about - Global Medical Marijuana Industry Analysis, Size, Growth, Trends and Forecast 2013 - 2025, click on this link – https://www.millioninsights.com/industry-reports/medical-marijuana-market

Application Outlook (Market Revenue in USD Million, 2013 - 2025)
• Chronic Pain
• Arthritis
• Migraine
• Cancer
• Others